The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Genomic Cancer Panel And Profiling Market During 2026–2030?
The genomic cancer panel and profiling market has demonstrated strong growth in recent years. It is anticipated to increase from $10.28 billion in 2025 to $11.17 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. This historical expansion can be attributed to factors such as growth in cancer prevalence, advancement in sequencing technologies, expansion of oncology diagnostics, increased funding for genomic research, and the rising adoption of precision medicine.
The market for genomic cancer panels and profiling is anticipated to experience substantial expansion in the coming years. This market is projected to reach $15.45 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.4%. Key drivers for this growth during the forecast period include the widening application of companion diagnostics, the rising uptake of liquid biopsy, the incorporation of AI into genomic analysis, an increase in oncology screening initiatives, and the creation of more economical sequencing platforms. Significant trends identified for the forecast timeframe encompass the expanding utilization of multi-gene cancer panels, the increasing deployment of next-generation sequencing, the broadening scope of liquid biopsy testing, a heightened need for personalized oncology solutions, and the seamless integration of genomic insights into clinical decision-making processes.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp
What Primary Drivers Are Shaping The Genomic Cancer Panel And Profiling Market?
An escalating incidence of cancer is anticipated to fuel the expansion of the genomic cancer panel and profiling market moving forward. This increase in cancer, a disease marked by the unrestrained proliferation and dissemination of atypical cells within the body, is largely attributable to an aging global populace, which elevates the probability of developing the condition as human longevity extends. Genomic cancer panels and profiling are instrumental in oncology care by identifying specific genetic mutations and biomarkers, thereby facilitating personalized treatment approaches and enhancing capabilities for early detection and ongoing monitoring. For example, in January 2024, the American Cancer Society, a U.S.-based nonprofit organization, reported that in 2022, approximately 20 million new cancer cases were recorded worldwide, resulting in 9.7 million deaths. Primarily driven by demographic growth, the global cancer burden is projected to reach 35 million cases by 2050. Hence, the increasing number of cancer diagnoses will stimulate the growth of the genomic cancer panel and profiling market.
Which Segment Classifications Are Used In The Genomic Cancer Panel And Profiling Market Segment Analysis?
The genomic cancer panel and profiling market covered in this report is segmented –
1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel
4) By Application: Clinical, Research
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users
Subsegments:
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids
Which Trends Are Impacting The Progress Of The Genomic Cancer Panel And Profiling Market?
Leading companies in the genomic cancer panel and profiling market are focusing on technological advancements, such as next-generation sequencers, to improve the precision, speed, and breadth of cancer diagnostics and enable more tailored treatment decisions. Next-generation sequencers represent sophisticated DNA sequencing technologies that allow for rapid, high-throughput analysis of genetic material to identify mutations, variations, and other genomic features. For instance, in April 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq panels specifically designed for next-generation sequencers, facilitating comprehensive genomic profiling by analyzing over 700 genes. These panels are intended for both research and clinical applications, aiming to enhance cancer diagnostics and treatment strategies.
Which Firms Are Contributing To The Genomic Cancer Panel And Profiling Market Ecosystem?
Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.
Get The Full Genomic Cancer Panel And Profiling Market Report:
Where Is The Genomic Cancer Panel And Profiling Market Primarily Concentrated By Region?
North America was the largest region in the genomic cancer panel and profiling market in 2025. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Genomic Cancer Panel And Profiling Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Genomic Cancer Panel And Profiling Market 2026, By The Business Research Company
Cancer Profiling Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report
Genomics In Cancer Care Market Report 2026
https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report
Cancer Tumor Profiling Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model